Burning Rock Biotech (BNR) Short-term Investments (2019 - 2026)

Burning Rock Biotech (BNR) has reported Short-term Investments for 8 consecutive years, with $395000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 26.6% year-over-year to $395000.0; the TTM figure through Mar 2026 stood at $395000.0 (up 26.6% YoY), while the FY2025 annual figure was $386000.0, up 21.77% from the prior year.
• Short-term Investments came in at $395000.0 for Q1 2026 at Burning Rock Biotech, up from $380116.1 in the prior quarter.
• The five-year high for Short-term Investments was $2.8 million in Q4 2022, with the low at $8000.0 in Q1 2024.
• Average Short-term Investments over 5 years is $548655.3, with a median of $322006.0 recorded in 2024.
• Across the five-year window, Short-term Investments tumbled 99.43% in 2024 and jumped 3800.0% in 2025, its largest moves.
• Year by year, Short-term Investments stood at $2.8 million in 2022, then sank by 99.4% to $16666.5 in 2023, then jumped by 1832.06% to $322006.0 in 2024, then gained by 18.05% to $380116.1 in 2025, then increased by 3.92% to $395000.0 in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $395000.0, $380116.1, and $419000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.